2021 Revenues ($USD) : $539,220,828
2021 Revenues (foreign currencies) : ¥57,578,000,000
2021 R&D spend : $14,984,079
2021 Number of Employees : not available
Fiscal Year End : 3/31/2021
Key People : Hiroaki Okukubo, president and representative director; Yasuhiro Awane,senior executive director, Surgical and Therapeutical Business Unit and Sales and Marketing Division; Ryuji Katsura, executive director. Corporate Affairs Division and Global Marketing Division; Masafumi Sato, director, Hospital Products Business Unit and Research and Development Division; Shogo Yanagida, director. Blood Management and Cell Therapy Business Unit and Production Division.

About the company: Dr. Taro Tsuchiya established JMS in the 1960s because he saw the need for disposable medical devices to reduce adverse events related to blood transfusion. Fast forward to today, and the company provides products and services related to infusion/transfusion, infusion/nutrition, dialysis, surgical treatment, and blood/cells. –CN